CASES SHOW
505(b)(2) Lyophilized Microspheres Accept FDA PAI Inspection (“Zero deficiency”)
Case Two
505(b)(2) Lyophilized Microspheres Accept FDA PAI Inspection (“Zero deficiency”)
KRB GMP team provided consulting services for a company's lyophilized microspheres to prepare and pass for FDA pre-approval inspection. The consulting services included gap analysis, hardware renovation guidance, re-validation consulting, personnel training, system optimization and enhancement, and technical support during the inspection. This product has a very complex sterilized management including sterilized lyophilization, sterilized powder dispensing, non-terminal sterilization pre-filled syringe and other technologies. Finally this project pass FDA PAI without deficiency which is also the first Chinese 505(b)(2) sterilized preparation pass FDA inspection.
CONTACT
Phone number:400-0123-669
Address:A805, Tower A, Chaowai SOHO, 6B Chaowai Street, Chaoyang District, Beijing 100020
Wechat account
Search for “KRB Consulting”
to know more!
Follow Us
Esperanto
Shqiptare
Euskara
Zulu
Latinus
Cymraeg
தமிழ்
Slovak
Slovak
Afrikaans
Copyright © 2023 KRB CONSULTING All Rights Reserved. 300.cn TAG Business License